Abstract:Aims: Alcohol is the most commonly used addictive substance and alcoholic liver disease (ALD) is a major cause of chronic liver disease worldwide, responsible for 47.9% of all liver chronic deaths. Despite ALD has a significant burden on the health, few therapeutic advances have been made in the last 40 years, particularly in the long-term management of these patients. Methods: we searched in PubMed, Scopus, Google Scholar, and MEDLINE databases to identify relevant English language publications focused on long-term therapy of ALD. Results: From the huge literature on this topic, including about 755 studies, 75 were selected as eligible including clinical trials and meta-analysis. Conclusions: Abstinence remains the cornerstone of ALD therapy but it is also the most difficult therapeutic target to achieve and the risk of recidivism is very high at any time. Several drugs (disulfiram, naltrexone, acamprosate, sodium oxybate) have proven to be effective to prevent alcohol relapse and increase the abstinence, although the psychotherapeutic support remains crucial. Baclofen seems to be effective to improve abstinence, showing an excellent safety and tolerability. ALD is often complicated by a state of malnutrition, which is related to a worst mortality. A nutritional therapy may improve survival in cirrhotic patients, reversing muscle wasting, weight loss and specific nutritional deficiencies. While in aggressive forms of alcoholic hepatitis are recommended specific drug treatments, including glucocorticoids or pentoxifylline, for the long-term treatment of ALD, specific treatments aimed at stopping the progression of fibrosis are not yet approved, but there are some future perspective in this field, including probiotics and antibiotics, caspase inhibitors, osteopontin and endocannabinoids.

New Drug Targets for Alcoholic Liver Disease

Noncoding RNAs in Alcoholic Liver Disease

Targeting Inflammation for the Treatment of Alcoholic Liver Disease.

New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

Pharmacotherapy of alcoholic liver disease in clinical practice

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Natural Compounds: A Potential Treatment for Alcoholic Liver Disease?

Current and future treatment for alcoholic‐related liver diseases

Natural compounds in the chemoprevention of alcoholic liver disease

Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy

Alcohol and the mechanisms of liver disease

Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment

Alcoholic Hepatitis: A Review

Alcohol-associated liver disease - a current overview

Alcoholic hepatitis: Translational approaches to develop targeted therapies

Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease

Roles of Gut Microbiota in Alcoholic Liver Disease

Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression

Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms

Deciphering the role of LncRNA in alcoholic liver disease: Mechanisms and therapeutic potential